METTL3 promotes microglial inflammation via MEF2C in spinal cord injury
- PMID: 38180567
- DOI: 10.1007/s00441-023-03855-6
METTL3 promotes microglial inflammation via MEF2C in spinal cord injury
Abstract
Spinal cord injury (SCI) is a significant contributor to disability in contemporary society, resulting in substantial psychological and economic burdens for patients and their family. Microglia-mediated inflammation is an important factor affecting the nerve repair of SCI patients. N6-methyladenosine (m6A) is a prevalent epigenetic modification in mammals, which shows a strong association with inflammation. However, the mechanism of m6A modification regulating microglia-mediated inflammation is still unclear. Here, we observed that METTL3, a m6A methylase, was increased in SCI mice and lipopolysaccharide (LPS)-exposed BV2 cells. Knockdown of METTL3 inhibited the increased expression of iNOS and IL-1β induced by LPS in vitro. Subsequently, MEF2C, myocyte-specific enhancer factor 2C, was decreased in SCI mice and LPS-exposed BV2 cells. Knockdown of MEF2C promoted the expression of iNOS and IL-1β. Sequence analysis showed that there were multiple highly confident m6A modification sites on the MEF2C mRNA. METTL3 antibody could pull down a higher level of MEF2C mRNA than the IgG in RNA binding protein immunoprecipitation assay. Knockdown of METTL3 promoted MEF2C protein expression and MEF2C mRNA expression, accompanied by a reduced m6A modification level on the MEF2C mRNA. Knockdown of MEF2C inhibited the anti-inflammatory effect of METTL3 siRNA. Our results suggest that METTL3 promotes microglia inflammation via regulating MEF2C mRNA m6A modification induced by SCI and LPS treatment.
Keywords: Inflammation; METTL3; Microglia; Spinal cord injury.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
USP1/UAF1-Stabilized METTL3 Promotes Reactive Astrogliosis and Improves Functional Recovery after Spinal Cord Injury through m6A Modification of YAP1 mRNA.J Neurosci. 2023 Mar 1;43(9):1456-1474. doi: 10.1523/JNEUROSCI.1209-22.2023. Epub 2023 Jan 18. J Neurosci. 2023. PMID: 36653190 Free PMC article.
-
The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-κB pathway.Neuroreport. 2022 Apr 6;33(6):243-251. doi: 10.1097/WNR.0000000000001550. Neuroreport. 2022. PMID: 33165191
-
Long noncoding RNA SNHG4 remits lipopolysaccharide-engendered inflammatory lung damage by inhibiting METTL3 - Mediated m6A level of STAT2 mRNA.Mol Immunol. 2021 Nov;139:10-22. doi: 10.1016/j.molimm.2021.08.008. Epub 2021 Aug 25. Mol Immunol. 2021. PMID: 34450538
-
METTL3 Promotes the Differentiation of Goat Skeletal Muscle Satellite Cells by Regulating MEF2C mRNA Stability in a m6A-Dependent Manner.Int J Mol Sci. 2023 Sep 14;24(18):14115. doi: 10.3390/ijms241814115. Int J Mol Sci. 2023. PMID: 37762418 Free PMC article.
-
SIX1 aggravates the progression of spinal cord injury in mice by promoting M1 polarization of microglia.Sci Rep. 2025 Jan 8;15(1):1283. doi: 10.1038/s41598-024-82121-3. Sci Rep. 2025. PMID: 39779741 Free PMC article.
Cited by
-
BARD1-mediated stabilization of METTL14 promotes retinal neovascularization by m6A-modifying MXD1 mRNA on a YTHDF2-dependent manner.Theranostics. 2025 Apr 13;15(11):5481-5498. doi: 10.7150/thno.110122. eCollection 2025. Theranostics. 2025. PMID: 40303324 Free PMC article.
References
-
- Chen J, Wang Z, Zheng Z, Chen Y, Khor S, Shi K, He Z, Wang Q, Zhao Y, Zhang H, Li X, Li J, Yin J, Wang X, Xiao J (2017) Neuron and Microglia/Macrophage-Derived Fgf10 Activate Neuronal Fgfr2/Pi3k/Akt Signaling and Inhibit Microglia/Macrophages Tlr4/Nf-Kappab-Dependent Neuroinflammation to Improve Functional Recovery after Spinal Cord Injury. Cell Death Dis 8:e3090 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical